Global and China Targeted Drugs for NSCLC Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Targeted Drugs for NSCLC industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Hetero Drugs

    • Pfizer

    • Fujifilm Kyowa Kirin Biologics

    • OSI Pharmaceuticals

    • Novartis

    • Glenmark Pharmaceuticals

    • Beacon Pharma Limited

    • Biocon

    • Allergan

    • Mylan

    • Genvio Pharma Limited

    • Natco Pharma

    • Roche

    • Reliance Lifesciences

    • BeiGene

    • Incepta Pharmaceuticals

    • AstraZeneca

    • Celgene Corporation

    • ImClone Systems ‎(Eli Lilly)

    • Teva

    • Amgen

    • Boehringer-Ingelheim

    • Drug International Limted

    • Cipla

    • ARIAD Pharmaceuticals (Takeda)

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Target EGFR

    • Target ALK

    • Target HER2

    • Target ROS1

    • Target BRAF

    • Target MEK

    • Target VEGFR2

    • Target VEGF

    • Target MET

    Application:

    • Squamous Cell Carcinoma of NSCLC

    • Adenocarcinoma of NSCLC

    • Large Cell Carcinoma of NSCLC

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Targeted Drugs for NSCLC Industry Overview

      • 1.1.1 Targeted Drugs for NSCLC Market Scope and Market Segments

      • 1.1.2 Targeted Drugs for NSCLC Industry Characteristics

      • 1.1.3 Global and China Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Targeted Drugs for NSCLC Production Value and Growth Rate (2017-2028)

    • 1.2 Global Targeted Drugs for NSCLC Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Target EGFR

      • 1.2.2 Target ALK

      • 1.2.3 Target HER2

      • 1.2.4 Target ROS1

      • 1.2.5 Target BRAF

      • 1.2.6 Target MEK

      • 1.2.7 Target VEGFR2

      • 1.2.8 Target VEGF

      • 1.2.9 Target MET

    • 1.3 Global Targeted Drugs for NSCLC Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Squamous Cell Carcinoma of NSCLC

      • 1.3.2 Adenocarcinoma of NSCLC

      • 1.3.3 Large Cell Carcinoma of NSCLC

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Targeted Drugs for NSCLC Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Targeted Drugs for NSCLC Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Targeted Drugs for NSCLC Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Targeted Drugs for NSCLC Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Targeted Drugs for NSCLC Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Targeted Drugs for NSCLC Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Targeted Drugs for NSCLC Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Targeted Drugs for NSCLC Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Targeted Drugs for NSCLC Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Targeted Drugs for NSCLC Industry Porter's Five Forces Model Analysis

      • 2.2.3 Targeted Drugs for NSCLC Industry PEST Analysis

    • 2.3 Targeted Drugs for NSCLC Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Targeted Drugs for NSCLC Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Targeted Drugs for NSCLC Industry

    Chapter 3 Global and China Targeted Drugs for NSCLC Market, by Manufacturer

    • 3.1 Global and China Targeted Drugs for NSCLC Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Targeted Drugs for NSCLC Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Targeted Drugs for NSCLC Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Targeted Drugs for NSCLC Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Targeted Drugs for NSCLC Market Top 3 Players

    Chapter 4 Global and China Targeted Drugs for NSCLC Market, by Type (2017-2028)

    • 4.1 Targeted Drugs for NSCLC Market Trend, by Type

    • 4.2 Global Targeted Drugs for NSCLC Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Targeted Drugs for NSCLC Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Targeted Drugs for NSCLC Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Targeted Drugs for NSCLC Price Trend, by Type (2017-2028)

    • 4.3 China Targeted Drugs for NSCLC Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Targeted Drugs for NSCLC Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Targeted Drugs for NSCLC Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Targeted Drugs for NSCLC Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Targeted Drugs for NSCLC Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Targeted Drugs for NSCLC Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Targeted Drugs for NSCLC Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Targeted Drugs for NSCLC Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Targeted Drugs for NSCLC Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Targeted Drugs for NSCLC Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Targeted Drugs for NSCLC Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Targeted Drugs for NSCLC Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Targeted Drugs for NSCLC Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Targeted Drugs for NSCLC Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Targeted Drugs for NSCLC Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Targeted Drugs for NSCLC Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Targeted Drugs for NSCLC Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Targeted Drugs for NSCLC Market Analysis

    • 7.1 North America Targeted Drugs for NSCLC Market, by Type

    • 7.2 North America Targeted Drugs for NSCLC Market, by Application

    • 7.3 North America Targeted Drugs for NSCLC Market Analysis and Forecast, by Country

      • 7.3.1 United States Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Targeted Drugs for NSCLC Market Analysis

    • 8.1 Europe Targeted Drugs for NSCLC Market, by Type

    • 8.2 Europe Targeted Drugs for NSCLC Market, by Application

    • 8.3 Europe Targeted Drugs for NSCLC Market Analysis and Forecast, by Country

      • 8.3.1 Germany Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Targeted Drugs for NSCLC Market Analysis

    • 9.1 APAC Targeted Drugs for NSCLC Market, by Type

    • 9.2 APAC Targeted Drugs for NSCLC Market, by Application

    • 9.3 APAC Targeted Drugs for NSCLC Market Analysis and Forecast, by Country

      • 9.3.1 China Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Targeted Drugs for NSCLC Market Analysis

    • 10.1 Latin America, Middle East and Africa Targeted Drugs for NSCLC Market, by Type

    • 10.2 Latin America, Middle East and Africa Targeted Drugs for NSCLC Market, by Application

    • 10.3 Latin America, Middle East and Africa Targeted Drugs for NSCLC Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Targeted Drugs for NSCLC Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Targeted Drugs for NSCLC Company Profiles

      • 11.1 Hetero Drugs

        • 11.1.1 Hetero Drugs Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Hetero Drugs Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.1.3 Hetero Drugs Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Pfizer

        • 11.2.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Pfizer Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.2.3 Pfizer Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Fujifilm Kyowa Kirin Biologics

        • 11.3.1 Fujifilm Kyowa Kirin Biologics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.3.3 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 OSI Pharmaceuticals

        • 11.4.1 OSI Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 OSI Pharmaceuticals Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.4.3 OSI Pharmaceuticals Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Novartis

        • 11.5.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Novartis Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.5.3 Novartis Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Glenmark Pharmaceuticals

        • 11.6.1 Glenmark Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.6.3 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Beacon Pharma Limited

        • 11.7.1 Beacon Pharma Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Beacon Pharma Limited Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.7.3 Beacon Pharma Limited Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Biocon

        • 11.8.1 Biocon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Biocon Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.8.3 Biocon Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Allergan

        • 11.9.1 Allergan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Allergan Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.9.3 Allergan Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Mylan

        • 11.10.1 Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Mylan Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.10.3 Mylan Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Genvio Pharma Limited

        • 11.11.1 Genvio Pharma Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Genvio Pharma Limited Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.11.3 Genvio Pharma Limited Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Natco Pharma

        • 11.12.1 Natco Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Natco Pharma Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.12.3 Natco Pharma Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Roche

        • 11.13.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Roche Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.13.3 Roche Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Reliance Lifesciences

        • 11.14.1 Reliance Lifesciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Reliance Lifesciences Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.14.3 Reliance Lifesciences Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 BeiGene

        • 11.15.1 BeiGene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 BeiGene Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.15.3 BeiGene Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Incepta Pharmaceuticals

        • 11.16.1 Incepta Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Incepta Pharmaceuticals Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.16.3 Incepta Pharmaceuticals Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 AstraZeneca

        • 11.17.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 AstraZeneca Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.17.3 AstraZeneca Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Celgene Corporation

        • 11.18.1 Celgene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Celgene Corporation Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.18.3 Celgene Corporation Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 ImClone Systems ‎(Eli Lilly)

        • 11.19.1 ImClone Systems ‎(Eli Lilly) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 ImClone Systems ‎(Eli Lilly) Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.19.3 ImClone Systems ‎(Eli Lilly) Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.20 Teva

        • 11.20.1 Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.20.2 Teva Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.20.3 Teva Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.21 Amgen

        • 11.21.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.21.2 Amgen Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.21.3 Amgen Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.22 Boehringer-Ingelheim

        • 11.22.1 Boehringer-Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.22.2 Boehringer-Ingelheim Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.22.3 Boehringer-Ingelheim Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.23 Drug International Limted

        • 11.23.1 Drug International Limted Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.23.2 Drug International Limted Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.23.3 Drug International Limted Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.24 Cipla

        • 11.24.1 Cipla Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.24.2 Cipla Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.24.3 Cipla Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.25 ARIAD Pharmaceuticals (Takeda)

        • 11.25.1 ARIAD Pharmaceuticals (Takeda) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.25.2 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Product Profiles, Application and Specification

        • 11.25.3 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Targeted Drugs for NSCLC Industry Investment Prospect and Risk Assessment

    • 12.1 Targeted Drugs for NSCLC Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Targeted Drugs for NSCLC Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure China Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Production Value and Growth Rate (2017-2028)

    • Figure China Targeted Drugs for NSCLC Production Value and Growth Rate (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target EGFR (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target ALK (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target HER2 (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target ROS1 (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target BRAF (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target MEK (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target VEGFR2 (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target VEGF (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target MET (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Market Size and Growth Rate of Squamous Cell Carcinoma of NSCLC (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Market Size and Growth Rate of Adenocarcinoma of NSCLC (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Market Size and Growth Rate of Large Cell Carcinoma of NSCLC (2017-2028)

    • Figure North America Targeted Drugs for NSCLC Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Targeted Drugs for NSCLC Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Targeted Drugs for NSCLC Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Targeted Drugs for NSCLC Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Targeted Drugs for NSCLC Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Targeted Drugs for NSCLC Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Targeted Drugs for NSCLC Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Targeted Drugs for NSCLC Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Targeted Drugs for NSCLC Market Share, by Manufacturer in 2021

    • Figure Global and China Targeted Drugs for NSCLC Market Share, by Manufacturer in 2022

    • Table Global Targeted Drugs for NSCLC Sales Volume, by Type (2017-2028)

    • Table Global Targeted Drugs for NSCLC Sales Volume Share, by Type (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Sales Volume Share, by Type (2017-2028)

    • Table Global Targeted Drugs for NSCLC Sales Value, by Type (2017-2028)

    • Table Global Targeted Drugs for NSCLC Sales Value Share, by Type (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Price Trend, by Type (2017-2028)

    • Table China Targeted Drugs for NSCLC Sales Volume, by Type (2017-2028)

    • Table China Targeted Drugs for NSCLC Sales Volume Share, by Type (2017-2028)

    • Figure China Targeted Drugs for NSCLC Sales Volume Share, by Type (2017-2028)

    • Table China Targeted Drugs for NSCLC Sales Value, by Type (2017-2028)

    • Table China Targeted Drugs for NSCLC Sales Value Share, by Type (2017-2028)

    • Figure China Targeted Drugs for NSCLC Price Trend, by Type (2017-2028)

    • Table Global Targeted Drugs for NSCLC Sales Volume, by Application (2017-2028)

    • Table Global Targeted Drugs for NSCLC Sales Volume Share, by Application (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Sales Volume Share, by Application (2017-2028)

    • Table Global Targeted Drugs for NSCLC Sales Value, by Application (2017-2028)

    • Table Global Targeted Drugs for NSCLC Sales Value Share, by Application (2017-2028)

    • Figure Global Targeted Drugs for NSCLC Sales Value Share, by Application (2017-2028)

    • Table China Targeted Drugs for NSCLC Sales Volume, by Application (2017-2028)

    • Table China Targeted Drugs for NSCLC Sales Volume Share, by Application (2017-2028)

    • Figure China Targeted Drugs for NSCLC Sales Volume Share, by Application (2017-2028)

    • Table China Targeted Drugs for NSCLC Sales Value, by Application (2017-2028)

    • Table China Targeted Drugs for NSCLC Sales Value Share, by Application (2017-2028)

    • Figure China Targeted Drugs for NSCLC Sales Value Share, by Application (2017-2028)

    • Figure China Targeted Drugs for NSCLC Production, Import, Consumption and Export (2017-2022)

    • Figure North America Targeted Drugs for NSCLC Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Targeted Drugs for NSCLC Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Targeted Drugs for NSCLC Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Targeted Drugs for NSCLC Production, Import, Consumption and Export (2017-2022)

    • Table North America Targeted Drugs for NSCLC Sales Volume, by Type (2017-2028)

    • Table North America Targeted Drugs for NSCLC Sales Volume Share, by Type (2017-2028)

    • Figure North America Targeted Drugs for NSCLC Sales Volume Share, by Type (2017-2028)

    • Table North America Targeted Drugs for NSCLC Sales Volume, by Application (2017-2028)

    • Table North America Targeted Drugs for NSCLC Sales Volume Share, by Application (2017-2028)

    • Figure North America Targeted Drugs for NSCLC Sales Volume Share, by Application (2017-2028)

    • Figure United States Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure United States Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure Canada Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Table Europe Targeted Drugs for NSCLC Sales Volume, by Type (2017-2028)

    • Table Europe Targeted Drugs for NSCLC Sales Volume Share, by Type (2017-2028)

    • Figure Europe Targeted Drugs for NSCLC Sales Volume Share, by Type (2017-2028)

    • Table Europe Targeted Drugs for NSCLC Sales Volume, by Application (2017-2028)

    • Table Europe Targeted Drugs for NSCLC Sales Volume Share, by Application (2017-2028)

    • Figure Europe Targeted Drugs for NSCLC Sales Volume Share, by Application (2017-2028)

    • Figure Germany Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure UK Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure UK Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure France Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure France Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure Italy Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure Spain Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure Poland Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure Russia Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Table APAC Targeted Drugs for NSCLC Sales Volume, by Type (2017-2028)

    • Table APAC Targeted Drugs for NSCLC Sales Volume Share, by Type (2017-2028)

    • Figure APAC Targeted Drugs for NSCLC Sales Volume Share, by Type (2017-2028)

    • Table APAC Targeted Drugs for NSCLC Sales Volume, by Application (2017-2028)

    • Table APAC Targeted Drugs for NSCLC Sales Volume Share, by Application (2017-2028)

    • Figure APAC Targeted Drugs for NSCLC Sales Volume Share, by Application (2017-2028)

    • Figure China Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure China Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure Japan Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure India Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure India Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Targeted Drugs for NSCLC Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Targeted Drugs for NSCLC Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Targeted Drugs for NSCLC Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Targeted Drugs for NSCLC Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Targeted Drugs for NSCLC Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Targeted Drugs for NSCLC Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Targeted Drugs for NSCLC Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Targeted Drugs for NSCLC Sales Value and Growth Rate (2017-2028)

    • Table Hetero Drugs Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hetero Drugs Product Profiles, Application and Specification

    • Table Hetero Drugs Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Fujifilm Kyowa Kirin Biologics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Fujifilm Kyowa Kirin Biologics Product Profiles, Application and Specification

    • Table Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table OSI Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table OSI Pharmaceuticals Product Profiles, Application and Specification

    • Table OSI Pharmaceuticals Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Glenmark Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Glenmark Pharmaceuticals Product Profiles, Application and Specification

    • Table Glenmark Pharmaceuticals Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Beacon Pharma Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Beacon Pharma Limited Product Profiles, Application and Specification

    • Table Beacon Pharma Limited Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biocon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biocon Product Profiles, Application and Specification

    • Table Biocon Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Allergan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Allergan Product Profiles, Application and Specification

    • Table Allergan Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mylan Product Profiles, Application and Specification

    • Table Mylan Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genvio Pharma Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genvio Pharma Limited Product Profiles, Application and Specification

    • Table Genvio Pharma Limited Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Natco Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Natco Pharma Product Profiles, Application and Specification

    • Table Natco Pharma Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Reliance Lifesciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Reliance Lifesciences Product Profiles, Application and Specification

    • Table Reliance Lifesciences Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BeiGene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BeiGene Product Profiles, Application and Specification

    • Table BeiGene Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Incepta Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Incepta Pharmaceuticals Product Profiles, Application and Specification

    • Table Incepta Pharmaceuticals Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Celgene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celgene Corporation Product Profiles, Application and Specification

    • Table Celgene Corporation Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ImClone Systems ‎(Eli Lilly) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ImClone Systems ‎(Eli Lilly) Product Profiles, Application and Specification

    • Table ImClone Systems ‎(Eli Lilly) Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Product Profiles, Application and Specification

    • Table Teva Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen Product Profiles, Application and Specification

    • Table Amgen Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer-Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer-Ingelheim Product Profiles, Application and Specification

    • Table Boehringer-Ingelheim Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Drug International Limted Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Drug International Limted Product Profiles, Application and Specification

    • Table Drug International Limted Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cipla Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cipla Product Profiles, Application and Specification

    • Table Cipla Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ARIAD Pharmaceuticals (Takeda) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ARIAD Pharmaceuticals (Takeda) Product Profiles, Application and Specification

    • Table ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.